J.Safra Asset Management Corp Vertex Pharmaceuticals Inc Transaction History
J.Safra Asset Management Corp
- $1.54 Billion
- Q3 2025
A detailed history of J.Safra Asset Management Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, J.Safra Asset Management Corp holds 20 shares of VRTX stock, worth $8,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$8,403% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,787Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$10.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.95 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.77 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.95 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $108B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...